Briefcases -- Drugs -- ELIQUIS (apixaban) MDL 2754 USDC SD New York

ELIQUIS (apixaban) MDL 2754 USDC SD New York

Case Files
News
Committees
Request a Document
Request
Search Within Briefcase

Folders

  1. JPML Initial Transfer and Consolidation Order
  2. Initial Case Filing Templates
    1. Plaintiff Fact Sheet(s)
    2. Defendant Fact Sheet(s)
  3. Court Orders
    1. Case Management Orders (CMOs)
    2. Leadership Committee and Appointments
  4. Case Pleadings
  5. Bellwether Cases
  6. Evidentiary and Research Documents
    1. Single Event Case Filings
    2. Media References
    3. FDA Regulatory Materials
  7. Transcripts

Quick Access

  1. ELIQUIS MDL 2754 (Proposed) CMO No. 5 Defendant Fact Sheets and Authorizations (April 28, 2017)
  2. ELIQUIS MDL 2754 (Proposed) CMO No. 4 Plaintiff Fact Sheets, Responses and Authorizations (April 28, 2017)
  3. ELIQUIS MDL 2754 (Proposed) CMO No. 1 Plaintiffs' Recommendations/Proposal for Plaintiffs' Steering Committee (April 7, 2017)
  4. ELIQUIS MDL 2754 (Proposed) CMO No. 1 Plaintiffs' Recommendations/Proposal for Plaintiffs' Steering Committee (April 7, 2017)
  5. ELIQUIS Lawyers' Review re: Bleeding Risks and Class Action (2015)
  6. ELIQUIS MDL 2754 Utts_Plaintiffs' Memorandum in Opposition to Motion to Dismiss (November 16, 2016)
  7. ELIQUIS Westlaw News Article re: Federal Judge Wipes out Nearly All Cases in Eliquis (November 29, 2017)
  8. ELIQUIS MDL 2754 JPML Transfer and Consolidation Order (February 7, 2017)